Experts see better glucose rates using dapagliflozin as add-on

06/30/2011 | Medscape (free registration)

Adding dapagliflozin to metformin therapy enhanced the treatment's efficacy in lowering blood glucose levels in patients newly diagnosed with type 2 diabetes, experts reported at the annual meeting of the American Diabetes Association. One study found that about 52% of patients on metformin-dapagliflozin treatment had hemoglobin A1c levels of 7% or less compared to 34.6% and 22.5% in those who only took either metformin or dapagliflozin, respectively. A second study had similar results.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD